RecruitingNCT00106015
Diamond Blackfan Anemia Registry (DBAR)
Sponsor
Northwell Health
Enrollment
900 participants
Start Date
Sep 1, 2004
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to maintain a comprehensive registry of patients with the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA).
Eligibility
Inclusion Criteria7
- Patients must meet the diagnostic criteria for DBA which include the following:
- Normochromic, usually macrocytic and occasionally normocytic anemia developing early in childhood
- Reticulocytopenia
- Normocellular bone marrow with a selective deficiency of red cell precursors
- Normal or slightly decreased leukocyte count
- Normal or often increased platelet count
- Or, a confirmed mutation in one of the identified DBA genes
Exclusion Criteria1
- Any subject identified as having another bone marrow failure syndrome (eg. Fanconi anemia, dyskeratosis congenita, Shwachman Diamond syndrome, etc.) will be excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00106015
Related Trials
Registry Platform Myelofibrosis and Anemia
NCT069769181 location
Study of DISC-0974-201 in Participants With IBD and Anemia
NCT073689726 locations
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
NCT0566473736 locations
Luspatercept for Clonal Cytopenias of Uncertain Significance
NCT067886911 location
Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
NCT073087697 locations